Mehta, A.; Motavaf, M.; Nebo, I.; Luyten, S.; Osei-Opare, K.D.; Gru, A.A.
Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy. J. Clin. Med. 2025, 14, 1200.
https://doi.org/10.3390/jcm14041200
AMA Style
Mehta A, Motavaf M, Nebo I, Luyten S, Osei-Opare KD, Gru AA.
Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy. Journal of Clinical Medicine. 2025; 14(4):1200.
https://doi.org/10.3390/jcm14041200
Chicago/Turabian Style
Mehta, Apoorva, Mateen Motavaf, Ikenna Nebo, Sophia Luyten, Kofi D. Osei-Opare, and Alejandro A. Gru.
2025. "Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy" Journal of Clinical Medicine 14, no. 4: 1200.
https://doi.org/10.3390/jcm14041200
APA Style
Mehta, A., Motavaf, M., Nebo, I., Luyten, S., Osei-Opare, K. D., & Gru, A. A.
(2025). Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy. Journal of Clinical Medicine, 14(4), 1200.
https://doi.org/10.3390/jcm14041200
